News

Article

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2004
Volume28
Issue 7

Characterization of the Performance of Bin Blenders Part 2 of 3: Free-Flowing Mixtures

Author(s):

Fernando Muzzio, PhD

In part two of a series of three articles, mixing rates and mechanisms are examined using rectangular bin blenders and two free-flowing mixtures.

External Link - article-109449.pdf

Articles in this issue
i1-143861-1408695852146.jpg
3M Drug Delivery Systems
i1-143960-1408695698259.jpg
AccuRate
July 2004
Characterization of the Performance of Bin Blenders Part 2 of 3: Free-Flowing Mixtures
Investors Shy Away from Pharmaceutical Chemicals
From CGMPs to the Critical Path: FDA Focuses on Innovation, Quality, and Continuous Improvement–Inside and Out

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 3rd 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 3rd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
South San Francisco, CA, USA - Mar 1, 2020: American clinical-stage biopharmaceutical company Cytokinetics, Inc.'s Headquarters in South San Francisco, California. | Image Credit: © Tada Images - stock.adobe.com
September 3rd 2025

Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
September 3rd 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Shanghai.China-Jan. 8th 2022: Fosun Pharma company logo on office building at night. A Chinese pharmaceutical company mostly owned by Fosun International | Image Credit: © Robert - stock.adobe.com
September 3rd 2025

Fosun Pharma to Exclusively Develop Accro Bioscience Anti-Inflammatory in China

Patrick Lavery
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 3rd 2025

Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Susan Haigney
© 2025 MJH Life Sciences

All rights reserved.